DexCom Logo

DexCom

🇺🇸
DXCM
US2521311074

DexCom is a leading US-based medical technology company and pioneer in continuous glucose monitoring (CGM). The company develops innovative systems for precise, real-time blood glucose monitoring. DexCom empowers individuals with diabetes to manage their glucose levels more effectively, enhancing quality of life and providing valuable data for healthcare.

Next Quarterly Earnings

Thursday, July 30, 2026
CW 31
After-Hours
In 17 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Currently in quiet period until July 30, 2026

Stock Price

Frequently asked questions

When will DexCom report its next quarterly earnings?

DexCom is scheduled to report its next quarterly earnings on 07/30/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did DexCom last report quarterly earnings?

DexCom last reported quarterly earnings on 4/30/2026 (Q2 2026). Earnings per share (EPS) came in at 0.56 USD.

How do I add the DexCom earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$0.61
Actual:
Q2 2026
Beat
Estimate:$0.47
Actual:$0.56
Difference:+$0.09
Q1 2026
Beat
Estimate:$0.65
Actual:$0.68
Difference:+$0.03

Company Information

Name
DexCom
Ticker Symbol
DXCM
ISIN
US2521311074
Country
🇺🇸
USA
Sector
Healthcare
Index membership
More Financial Information